Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

HFMs can help study hair growth and test potential hair growth drugs.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.